Cite
HARVARD Citation
Mittelman, M. et al. (2018). Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. Lancet. 5 (1), pp. e34-e43. [Online].